| Title |
Overview of neurosarcoidosis: recent advances
|
|---|---|
| Published in |
Journal of Neurology, September 2014
|
| DOI | 10.1007/s00415-014-7482-9 |
| Pubmed ID | |
| Authors |
Renata Hebel, Mirosława Dubaniewicz-Wybieralska, Anna Dubaniewicz |
| Abstract |
Sarcoidosis (SA) is a granulomatous, multisystem disease of unknown etiology. Most often the disease affects lungs and mediastinal lymph nodes, but it may occur in other organs. Neurosarcoidosis (NS) more commonly occurs with other sarcoidosis forms, in 1 % of cases it involves only nervous system. Symptomatic NS occurs but on autopsy study up to 25 % of cases are confirmed. NS can affect central nervous system: the brain, spinal cord and peripheral nerves, and muscles. The diagnosis of neurosarcoidosis facilitates diagnostic criteria: histopathological, imaging and cerebrospinal fluid examination, and clinical symptoms. At present, there are no set standards for treatment of patients suffering from NS. Early therapy of symptomatic patients is recommended. Corticosteroids still are the first line of treatment for NS patients. In cases of steroids resistance, lack of their effectiveness or existence of contraindication to their use, immunosuppressant treatment is recommended. The latest NS algorithm with immunosuppressive treatment is discussed. |
Mendeley readers
The data shown below were compiled from readership statistics for 109 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Romania | 1 | <1% |
| Unknown | 107 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 19 | 17% |
| Researcher | 17 | 16% |
| Student > Doctoral Student | 10 | 9% |
| Student > Bachelor | 10 | 9% |
| Student > Ph. D. Student | 9 | 8% |
| Other | 25 | 23% |
| Unknown | 19 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 56 | 51% |
| Neuroscience | 11 | 10% |
| Biochemistry, Genetics and Molecular Biology | 3 | 3% |
| Physics and Astronomy | 2 | 2% |
| Engineering | 2 | 2% |
| Other | 8 | 7% |
| Unknown | 27 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 February 2015.
All research outputs
#18,381,794
of 22,768,097 outputs
Outputs from Journal of Neurology
#3,633
of 4,468 outputs
Outputs of similar age
#170,251
of 238,757 outputs
Outputs of similar age from Journal of Neurology
#35
of 54 outputs
Altmetric has tracked 22,768,097 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,468 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 238,757 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.